Michel Morre, DVM, Founder, President and Chief Executive Officer
Dr. Morre is President of the Executive Management Board (Directoire) and Founder of Cytheris. With more than 30 years of industry experience in pharmaceutical research and development, Michel brings to Cytheris a background in international drug research and skills in management of large projects. In particular, at Sanofi-Aventis he managed the full European pre-clinical and clinical development program for recombinant human growth hormone, the first biotech product introduced to the French market. He is a graduate of the National School of Veterinary Medicine, Toulouse, France, and conducted post-doctoral research at the Massachusetts Institute of Technology.